These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16766026)

  • 1. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition.
    Ponce S; Orive G; Hernández R; Gascón AR; Pedraz JL; de Haan BJ; Faas MM; Mathieu HJ; de Vos P
    Biomaterials; 2006 Oct; 27(28):4831-9. PubMed ID: 16766026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zeta-potentials of alginate-PLL capsules: a predictive measure for biocompatibility?
    de Vos P; de Haan BJ; Kamps JA; Faas MM; Kitano T
    J Biomed Mater Res A; 2007 Mar; 80(4):813-9. PubMed ID: 17058213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two types of alginate microcapsules on stability and biocompatibility in vitro and in vivo.
    Li HB; Jiang H; Wang CY; Duan CM; Ye Y; Su XP; Kong QX; Wu JF; Guo XM
    Biomed Mater; 2006 Mar; 1(1):42-7. PubMed ID: 18458385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating.
    King A; Strand B; Rokstad AM; Kulseng B; Andersson A; Skjåk-Braek G; Sandler S
    J Biomed Mater Res A; 2003 Mar; 64(3):533-9. PubMed ID: 12579568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules.
    Clayton HA; London NJ; Colloby PS; Bell PR; James RF
    J Microencapsul; 1991; 8(2):221-33. PubMed ID: 1765902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period.
    de Vos P; van Hoogmoed CG; de Haan BJ; Busscher HJ
    J Biomed Mater Res; 2002 Dec; 62(3):430-7. PubMed ID: 12209929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility and physicochemical characteristics of alginate-polycation microcapsules.
    Tam SK; Bilodeau S; Dusseault J; Langlois G; Hallé JP; Yahia LH
    Acta Biomater; 2011 Apr; 7(4):1683-92. PubMed ID: 21145438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy.
    Orive G; Tam SK; Pedraz JL; Hallé JP
    Biomaterials; 2006 Jul; 27(20):3691-700. PubMed ID: 16574222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Poly-L-Ornithine-coated alginate microcapsules.
    Darrabie MD; Kendall WF; Opara EC
    Biomaterials; 2005 Dec; 26(34):6846-52. PubMed ID: 15955558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the tissue response against alginate-pll capsules by temporary release of co-encapsulated steroids.
    Bünger CM; Tiefenbach B; Jahnke A; Gerlach C; Freier T; Schmitz KP; Hopt UT; Schareck W; Klar E; de Vos P
    Biomaterials; 2005 May; 26(15):2353-60. PubMed ID: 15585238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical model of alginate-poly-L-lysine microcapsules defined at the micrometric/nanometric scale using ATR-FTIR, XPS, and ToF-SIMS.
    Tam SK; Dusseault J; Polizu S; Ménard M; Hallé JP; Yahia L
    Biomaterials; 2005 Dec; 26(34):6950-61. PubMed ID: 15975648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules.
    Haque T; Chen H; Ouyang W; Martoni C; Lawuyi B; Urbanska AM; Prakash S
    Mol Pharm; 2005; 2(1):29-36. PubMed ID: 15804175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility and membrane strength of C3H10T1/2 cell-loaded alginate-based microcapsules.
    Zhang WJ; Li BG; Zhang C; Xie XH; Tang TT
    Cytotherapy; 2008; 10(1):90-7. PubMed ID: 18202978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules.
    Ponce S; Orive G; Hernández RM; Gascón AR; Canals JM; Muñoz MT; Pedraz JL
    J Control Release; 2006 Nov; 116(1):28-34. PubMed ID: 17081643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules.
    De Castro M; Orive G; Hernández RM; Bartkowiak A; Brylak W; Pedraz JL
    J Biomed Mater Res A; 2009 Dec; 91(4):1119-30. PubMed ID: 19145624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fourier transform infrared spectroscopy studies of alginate-PLL capsules with varying compositions.
    van Hoogmoed CG; Busscher HJ; de Vos P
    J Biomed Mater Res A; 2003 Oct; 67(1):172-8. PubMed ID: 14517874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines.
    Strand BL; Ryan TL; In't Veld P; Kulseng B; Rokstad AM; Skjak-Brek G; Espevik T
    Cell Transplant; 2001; 10(3):263-75. PubMed ID: 11437072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatibility evaluation of different alginates and alginate-based microcapsules.
    Orive G; Carcaboso AM; Hernández RM; Gascón AR; Pedraz JL
    Biomacromolecules; 2005; 6(2):927-31. PubMed ID: 15762661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of alginate-poly-L-lysine-alginate microcapsules by confocal laser scanning microscopy.
    Strand BL; Mørch YA; Espevik T; Skjåk-Braek G
    Biotechnol Bioeng; 2003 May; 82(4):386-94. PubMed ID: 12632394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells.
    de Vos P; Hoogmoed CG; Busscher HJ
    J Biomed Mater Res; 2002 May; 60(2):252-9. PubMed ID: 11857431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.